Search

Search Constraints

You searched for: Author/Creator Zephir, Helene

Search Results

1. Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD. (9th February 2021)

2. Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease. Issue 1 (15th October 2020)

3. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. (22nd May 2018)

4. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis. (25th October 2022)

5. DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France. Issue 8 (7th July 2021)

6. DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France. Issue 8 (7th July 2021)

7. Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders. (September 2017)

8. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders. Issue 1 (16th January 2022)

9. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders. Issue 1 (January 2022)

10. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference. (21st March 2023)